請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29550
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蘇慧敏(Hui-Min Su) | |
dc.contributor.author | I-Fen Lu | en |
dc.contributor.author | 呂怡芬 | zh_TW |
dc.date.accessioned | 2021-06-13T01:10:09Z | - |
dc.date.available | 2012-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-20 | |
dc.identifier.citation | Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M (2004) S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun 316:878-883.
Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M (2005) Palmitoylation-dependent Estrogen Receptor {alpha} Membrane Localization: Regulation by 17{beta}-Estradiol. In, pp 231-237. Allred DC, Brown P, Medina D (2004) The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 6:240-245. Arnold SF, Obourn JD, Jaffe H, Notides AC (1994) Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. In, pp 1208-1214. Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB (2002) MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene 21:4000-4008. Bagga D, Anders KH, Wang HJ, Glaspy JA (2002) Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer 42:180-185. Bjornstrom L, Sjoberg M (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842. Borras M, Hardy L, Lempereur F, el Khissiin AH, Legros N, Gol-Winkler R, Leclercq G (1994) Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48:325-336. Borras M, Laios I, el Khissiin A, Seo HS, Lempereur F, Legros N, Leclercq G (1996) Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 57:203-213. Bundred NJ (2001) Prognostic and predictive factors in breast cancer. Cancer Treat Rev 27:137-142. Bunone G, Briand PA, Miksicek RJ, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. Embo J 15:2174-2183. Cakir Y, Plummer HK, 3rd, Tithof PK, Schuller HM (2002) beta adrenergic and arachidonic acid-mediated growth regulation of himan breast cancer lines. Int J Oncol 21:153-157. Calder PC, Yaqoob P (2007) Lipid rafts--composition, characterization, and controversies. J Nutr 137:545-547. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P (2004) n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25:2303-2310. Carroll KK (1975) Experimental Evidence of Dietary Factors and Hormone-dependent Cancers. In, pp 3374-3383. Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, Rago V, Montanaro D, Maggiolini M, Panno ML, Ando S (2004) Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem 279:19908-19915. Chamras H, Ardashian A, Heber D, Glaspy JA (2002) Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13:711-716. Chen W, Jump DB, Esselman WJ, Busik JV (2007) Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 48:18-26. Chi TY, Chen GG, Lai PB (2004) Eicosapentaenoic acid induces Fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells. Cancer J 10:190-200. Chunhua Qin ISSNSS (2004) Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways. In, pp 160-170. Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between Steroid Receptor Expression and Cell Proliferation in the Human Breast. In, pp 4987-4991. Connolly JM, Gilhooly EM, Rose DP (1999) Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer 35:44-49. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS (1996) Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29550 | - |
dc.description.abstract | 乳癌對女性的健康造成極大的威脅。根據美國癌症協會的統計資料指出,婦女罹患乳癌的機率已攀升至31%;且致死率更升高為26%。而超過百分之六十的乳癌病患,歸類於雌激素-依賴性(estrogen -dependent)的乳癌。此類乳癌細胞中雌激素接受器α(Estrogen receptor α;ERα)有過量表現的情形,而且ERα在雌激素(17β-Estradiol;E2)的刺激下,會透過訊息傳遞以及ERα轉錄活性的增加,而促進乳癌細胞的增生與惡化。流行病學研究發現,富含多元不飽和脂肪酸DHA (docosahexaenoic acid, C22:6n-3) 的深海魚油,可降低乳癌的發生率,但可能發生機轉仍不詳。因此本論文的目的,為探討DHA是否藉由調控ERα在乳癌細胞中的表現與分佈及其訊息傳遞,而降低乳癌細胞的生長。
研究利用人類乳癌細胞株,MCF-7 cells,為estrogen-dependent且表現ERα的乳癌細胞。細胞培養在含有1% Dextran-charcoal 處理過的胎牛血清且phenol-red free DMEM培養液中,並添加不同濃度的DHA處理。從實驗的結果發現:當添加不同濃度的DHA( 0~100μM )處理24小時後,MCF-7中 DHA 含量占所有脂肪酸重量百分比亦隨之增加;從0.3、3.4、4.7、5.2、8.2、10.5、12.3 增加至14.4 wt %。而從細胞的存活率分析可知DHA的添加會抑制MCF-7的生長,使存活率下降14 % 至40 %。而對於ERα 的影響,則發現MCF-7添加DHA 10或60 μM處理24小時之後,再給予10 nM E2 作用4小時,DHA可以使細胞質中的ERα表現量分別下降32及29 %,但並不影響ERα在細胞核內的表現量。而60 μM DHA處理48小時後,除了使細胞核中ERα表現量降低26.2 %,亦降低25 % ER α在細胞中的總表現量。在與ER α有關的訊息傳遞反應方面,發現在E2的刺激下,其DHA的添加明顯降低MCF-7內mitogen activated protein kinases(MAPK)的磷酸化表現,使其下降56%。且從免疫螢光的影像顯示,添加DHA會減少ERα在細胞質及細胞膜上的分佈。 本篇論文利用人類乳癌細胞MCF-7 cells,探討DHA 對乳癌細胞內ERα的表現及其分佈調控,發現DHA可進入MCF-7,增加其細胞內DHA的含量;並可抑制細胞的生長。且DHA的添加可影響ERα在MCF-7內的表現及在細胞質與細胞核中的分佈;DHA的添加明顯降低ERα在MCF-7細胞質中的分佈,而且可降低由E2刺激所引起的MAPK磷酸化。總而言之,DHA可以調控estrogen-dependent乳癌細胞內ER α的表現與分佈及MAPK的活性,進而降低E2對乳癌細胞的作用。本論文將有助於臨床上estrogen-dependent乳癌治療,且期許有所貢獻。 | zh_TW |
dc.description.abstract | Many studies showed that docosahexaenoic acid (DHA, 22:6n-3)-rich fish oil decrease breast cancer incidence. However, the mechanism is still not clear. The aim of this study is to investigate DHA may regulate estrogen receptor α (ERα) distribution, expression and its signal transduction by changing the DHA level studied in MCF-7, a hormone dependent human breast cancer cell lines.
MCF-7 were incubated in phenol red free-DMEM with 1% Dextran-Charcoal treated FBS supplemented with DHA followed by 10 nM E2 stimulation. It was found that the DHA level was increased from 0.3, 3.4, 4.7, 5.2, 8.2, 10.5, 12.3 and 14.4 % of total fatty acids with the increasing 0、5、10、20、40、 60、 80、100 μM DHA supplementation for 24 hrs, respectively. The viability of MCF-7 was decreased 14 ~ 40% of the controls with the increasing DHA supplementation for 24 hrs.ERα expression in cytosol but not in nucleus was reduced 32 % or 29 % with DHA 10 or 60 uM supplementation for 24 hrs, respectively. ERα expression was significant down regulation not only in cytosol, but also in nucleus and whole cells supplemented with 60 μM DHA for 48 hrs. And the phosphorylated p44/42 MAPK expression was declined 56 % of controls with DHA supplementation for 24 hrs followed by 10 nM E2 stimulating for 15 minutes. The cytosolic ERα staining was diminished in MCF-7 with DHA supplementation. In conclusion, DHA supplementation did increase DHA level, reduce its viability, decrease cytosolic ERα distribution, and phosphorylated p44/42 MAPK expression in MCF-7. It was suggested that DHA may down regulate the E2 actions on estrogen dependent breast cancer cells via modulate ERα distribution. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T01:10:09Z (GMT). No. of bitstreams: 1 ntu-96-R93441004-1.pdf: 1058304 bytes, checksum: a06049812c847d6b21e689eb71b9bc7b (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 中文摘要 Ⅰ
英文摘要 Ⅲ 目錄 Ⅳ 圖表目錄 Ⅶ 第一章 文獻回顧 一、乳癌簡介 1 二、雌激素接受器α(estrogen receptor α;ERα) 2 (一) ERα簡介 2 (二) ERα與乳癌的關係 3 (三) ERα的訊息傳遞路徑 3 (四) ERα的分佈 6 三、多元不飽和脂肪酸 ( Polyunsaturated fatty acids ) 7 (一)多元不飽和脂肪酸簡介 7 (二)多元不飽和脂肪酸n-3 fatty acid與癌症之關係 7 (三)多元不飽和脂肪酸n-3 fatty acid抗癌的作用機轉 8 (四)多元不飽和脂肪酸n-3 fatty acid與脂筏(lipid raft)8 第二章 研究目的 一、研究動機 10 二、實驗假說 11 三、研究的重要性 12 第三章 材料與方法 一、細胞培養 13 (一)人類乳癌細胞株 MCF-7 13 (二)細胞培養條件 13 (三)實驗條件 14 二、配置Dextran-charcoal treated FBS 16 三、DHA (或AA) 1000 uM stock 的配製 17 四、細胞存活率分析(cell viability) 17 五、脂肪酸分析 18 六、蛋白質的定性與定量分析 19 (一)蛋白質的萃取 19 (二)蛋白質定量法 20 (三)電泳檢定法 21 (四)西方轉染法 22 (五)酵素免疫染色法 23 (六)壓片 24 (七)定量與標準化 24 七、免疫螢光染色 25 八、純度分析檢查 26 九、統計方法 26 第四章 結果 一、DHA與MCF-7細胞脂肪酸成分 27 二、DHA與MCF-7 的生長 30 三、DHA與MCF-7 ERα的表現量 32 四、DHA與MCF-7 ERα在細胞質與細胞核之分佈 34 五、DHA與p42/44 MAP Kinase磷酸化表現 37 六、DHA與ERα的分佈位置 39 第五章 討論 一、實驗條件之建立 41 二、DHA進入(incorporation into)MCF-7 42 三、DHA與MCF-7的生長 42 四、DHA與MCF-7細胞內ERα的表現量 43 五、DHA與MCF-7內MAPK的活化 46 六、MAPK活化與ERα在MCF-7細胞內的分佈 47 七、AA的效應 47 第六章 總結 49 附錄一 Appendex A~G 51 附錄二 藥品試劑項目 59 附錄三 藥品與試劑的配製 61 參考文獻 65 圖表目錄 Table 1 Effect of DHA supplementation on fatty acid composition of MCF-7 28 Figure 1 Model and Hypothesis 11 Figure 2 Experimental Design 15 Figure 3 Purity Examination 26 Figure 4 The DHA incorporation into MCF-7 cells 29 Figure 5 Effect of DHA on the viability of MCF-7 cells 31 Figure 6 Effect of DHA and AA supplementation on ERα expression in whole MCF-7 cells 33 Figure 7 Effect of DHA and AA supplementation on ERα expression in cytosol and nucleus of MCF-7 cells 36 Figure 8 Effect of DHA and AA supplementation on phosphorylation of p42/44 MAP kinase expression in MCF-7 cells 38 Figure 9 Effect of DHA supplementation on the ERα distribution in cytolsol and nucleus of MCF-7 40 | |
dc.language.iso | zh-TW | |
dc.title | 探討DHA對人類乳癌細胞雌激素接受器α分佈之影響 | zh_TW |
dc.title | Effect of docosahexaenoic acid on estrogen receptor α distribution studied in human breast cancer cell lines | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 呂紹俊(Shao-Chun Lu),胡孟君(Meng-Chun Hu),黃青真(Ching-Jang Huang) | |
dc.subject.keyword | 乳癌,二十二碳六烯酸,雌激素接受器, | zh_TW |
dc.subject.keyword | docosahexaenoic acid,estrogen receptor α,breast cancer, | en |
dc.relation.page | 74 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-23 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生理學研究所 | zh_TW |
顯示於系所單位: | 生理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 1.03 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。